{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:52:01Z","timestamp":1794667921862,"version":"4.9.1"},"reference-count":59,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:00:00Z","timestamp":1768262400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T00:00:00Z","timestamp":1770595200000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["82473834"],"award-info":[{"award-number":["82473834"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China,China","doi-asserted-by":"crossref","award":["82373780"],"award-info":[{"award-number":["82373780"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"\u201cDouble First-Class\u201d University Project","award":["CPU2022PZQ10"],"award-info":[{"award-number":["CPU2022PZQ10"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neuroinflammation"],"DOI":"10.1186\/s12974-025-03683-1","type":"journal-article","created":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T03:24:48Z","timestamp":1768274688000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["IL-27, a metabolic regulator secreted by astrocytes in response to GLP-1RA OHP2, modulates microglial reprogramming in Alzheimer\u2019s disease by regulating cGAS lactylation"],"prefix":"10.1186","volume":"23","author":[{"given":"Yixuan","family":"Du","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingxi","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Mao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Song","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangdong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,13]]},"reference":[{"key":"3683_CR1","doi-asserted-by":"publisher","first-page":"115522","DOI":"10.1016\/j.bcp.2023.115522","volume":"211","author":"AR Monteiro","year":"2023","unstructured":"Monteiro AR, Barbosa DJ, Remi\u00e3o F, Silva R. Alzheimer\u2019s disease: insights and new prospects in disease pathophysiology, biomarkers and disease-modifying drugs. Biochem Pharmacol. 2023;211:115522.","journal-title":"Biochem Pharmacol"},{"key":"3683_CR2","first-page":"e105","volume":"7","author":"E Nichols","year":"2022","unstructured":"Nichols E, Steinmetz JD, Vollset SE, Fukutaki K, Chalek J, Abd-Allah F, et al. Estimation of the global prevalence of dementia in 2019 and forecasted prevalence in 2050: an analysis for the global burden of disease study 2019. Lancet. 2022;7:e105\u201325.","journal-title":"Lancet"},{"key":"3683_CR3","doi-asserted-by":"crossref","unstructured":"Alzheimer's Association. 2025 Alzheimer\u2019s disease facts and figures. Alzheimers Dement. 2025;11(3):332\u2013384.","DOI":"10.1016\/j.jalz.2015.02.003"},{"key":"3683_CR4","doi-asserted-by":"publisher","first-page":"2181","DOI":"10.7150\/ijbs.57078","volume":"17","author":"H Zhang","year":"2021","unstructured":"Zhang H, Wei W, Zhao M, Ma L, Jiang X, Pei H, et al. Interaction between A\u03b2 and Tau in the pathogenesis of alzheimer\u2019s disease. Int J Biol Sci. 2021;17:2181\u201392.","journal-title":"Int J Biol Sci"},{"key":"3683_CR5","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.neulet.2019.04.022","volume":"705","author":"NN Naseri","year":"2019","unstructured":"Naseri NN, Wang H, Guo J, Sharma M, Luo W. The complexity of Tau in alzheimer\u2019s disease. Neurosci Lett. 2019;705:183\u201394.","journal-title":"Neurosci Lett"},{"key":"3683_CR6","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.cell.2015.12.056","volume":"164","author":"B De Strooper","year":"2016","unstructured":"De Strooper B, Karran E. The cellular phase of alzheimer\u2019s disease. Cell. 2016;164:603\u201315.","journal-title":"Cell"},{"key":"3683_CR7","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.semcdb.2022.05.028","volume":"139","author":"J Griffiths","year":"2023","unstructured":"Griffiths J, Grant SGN. Synapse pathology in alzheimer\u2019s disease. Semin Cell Dev Biol. 2023;139:13\u201323.","journal-title":"Semin Cell Dev Biol"},{"key":"3683_CR8","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1038\/nn.4017","volume":"18","author":"K Herrup","year":"2015","unstructured":"Herrup K. The case for rejecting the amyloid cascade hypothesis. Nat Neurosci. 2015;18:794\u20139.","journal-title":"Nat Neurosci"},{"key":"3683_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s40035-022-00292-3","volume":"11","author":"C Song","year":"2022","unstructured":"Song C, Shi J, Zhang P, Zhang Y, Xu J, Zhao L, et al. Immunotherapy for alzheimer\u2019s disease: targeting \u03b2-amyloid and beyond. Transl Neurodegener. 2022;11:18.","journal-title":"Transl Neurodegener"},{"key":"3683_CR10","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1186\/s40035-025-00465-w","volume":"14","author":"B-H Kim","year":"2025","unstructured":"Kim B-H, Kim S, Nam Y, Park YH, Shin SM, Moon M. Second-generation anti-amyloid monoclonal antibodies for alzheimer\u2019s disease: current landscape and future perspectives. Transl Neurodegener. 2025;14:6.","journal-title":"Transl Neurodegener"},{"key":"3683_CR11","doi-asserted-by":"publisher","first-page":"106631","DOI":"10.1016\/j.phrs.2022.106631","volume":"187","author":"BP Imbimbo","year":"2023","unstructured":"Imbimbo BP, Ippati S, Watling M, Imbimbo C. Role of monomeric amyloid-\u03b2 in cognitive performance in alzheimer\u2019s disease: insights from clinical trials with secretase inhibitors and monoclonal antibodies. Pharmacol Res. 2023;187:106631.","journal-title":"Pharmacol Res"},{"key":"3683_CR12","doi-asserted-by":"publisher","first-page":"578342","DOI":"10.1016\/j.jneuroim.2024.578342","volume":"390","author":"S Fruhw\u00fcrth","year":"2024","unstructured":"Fruhw\u00fcrth S, Zetterberg H, Paludan SR. Microglia and amyloid plaque formation in alzheimer\u2019s disease \u2013 Evidence, possible mechanisms, and future challenges. J Neuroimmunol. 2024;390:578342.","journal-title":"J Neuroimmunol"},{"key":"3683_CR13","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1146\/annurev-immunol-032713-120240","volume":"32","author":"D Nayak","year":"2014","unstructured":"Nayak D, Roth TL, McGavern DB. Microglia development and Function*. Annu Rev Immunol. 2014;32:367\u2013402.","journal-title":"Annu Rev Immunol"},{"key":"3683_CR14","doi-asserted-by":"crossref","unstructured":"Fernando KKM, Wijayasinghe YS. Sirtuins as potential therapeutic targets for mitigating neuroinflammation associated with alzheimer\u2019s disease. Front Cell Neurosci. 2021;15:746631.","DOI":"10.3389\/fncel.2021.746631"},{"key":"3683_CR15","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1111\/bph.13139","volume":"173","author":"R Orihuela","year":"2016","unstructured":"Orihuela R, McPherson CA, Harry GJ. Microglial M1\/M2 polarization and metabolic States. Br J Pharmacol. 2016;173:649\u201365.","journal-title":"Br J Pharmacol"},{"key":"3683_CR16","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1016\/j.jmb.2019.03.006","volume":"431","author":"BI Aldana","year":"2019","unstructured":"Aldana BI. Microglia-Specific metabolic changes in neurodegeneration. J Mol Biol. 2019;431:1830\u201342.","journal-title":"J Mol Biol"},{"key":"3683_CR17","doi-asserted-by":"crossref","unstructured":"Shemer A, Scheyltjens I, Frumer GR, Kim J-S, Grozovski J, Ayanaw S et al. Interleukin-10 Prevents Pathological Microglia Hyperactivation following Peripheral Endotoxin Challenge. Immunity.2020;53(5):1033\u20131049.e7.","DOI":"10.1016\/j.immuni.2020.09.018"},{"key":"3683_CR18","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s13024-019-0305-9","volume":"14","author":"L Wang","year":"2019","unstructured":"Wang L, Pavlou S, Du X, Bhuckory M, Xu H, Chen M. Glucose transporter 1 critically controls microglial activation through facilitating Glycolysis. Mol Neurodegener. 2019;14:2.","journal-title":"Mol Neurodegener"},{"key":"3683_CR19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.cmet.2022.02.013","volume":"34","author":"R-Y Pan","year":"2022","unstructured":"Pan R-Y, He L, Zhang J, Liu X, Liao Y, Gao J, et al. Positive feedback regulation of microglial glucose metabolism by histone H4 lysine 12 lactylation in alzheimer\u2019s disease. Cell Metab. 2022;34:634\u2013e6486.","journal-title":"Cell Metab"},{"key":"3683_CR20","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1007\/s10571-023-01376-y","volume":"43","author":"J Miao","year":"2023","unstructured":"Miao J, Chen L, Pan X, Li L, Zhao B, Lan J. Microglial metabolic reprogramming: emerging insights and therapeutic strategies in neurodegenerative diseases. Cell Mol Neurobiol. 2023;43:3191\u2013210.","journal-title":"Cell Mol Neurobiol"},{"key":"3683_CR21","doi-asserted-by":"publisher","first-page":"3473","DOI":"10.1111\/bph.15069","volume":"177","author":"W Lu","year":"2020","unstructured":"Lu W, Tian H, Qian P, Li Y, Wang Y, Ge Y, et al. An orally available hypoglycaemic peptide taken up by caveolae transcytosis displays improved hypoglycaemic effects and body weight control in db\/db mice. Br J Pharmacol. 2020;177:3473\u201388.","journal-title":"Br J Pharmacol"},{"key":"3683_CR22","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.tins.2020.01.003","volume":"43","author":"ID Vainchtein","year":"2020","unstructured":"Vainchtein ID, Molofsky AV. Astrocytes and microglia: in sickness and in health. Trends Neurosci. 2020;43:144\u201354.","journal-title":"Trends Neurosci"},{"key":"3683_CR23","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1126\/science.aal3589","volume":"359","author":"ID Vainchtein","year":"2018","unstructured":"Vainchtein ID, Chin G, Cho FS, Kelley KW, Miller JG, Chien EC, et al. Astrocyte-derived interleukin-33 promotes microglial synapse engulfment and neural circuit development. Science. 2018;359:1269\u201373.","journal-title":"Science"},{"key":"3683_CR24","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-021-03734-6","volume":"595","author":"CS McAlpine","year":"2021","unstructured":"McAlpine CS, Park J, Griciuc A, Kim E, Choi SH, Iwamoto Y, et al. Astrocytic interleukin-3 programs microglia and limits alzheimer\u2019s disease. Nature. 2021;595:701\u20136.","journal-title":"Nature"},{"key":"3683_CR25","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1038\/ni.2366","volume":"13","author":"DAA Vignali","year":"2012","unstructured":"Vignali DAA, Kuchroo VK. IL-12 family cytokines: immunological playmakers. Nat Immunol. 2012;13:722\u20138.","journal-title":"Nat Immunol"},{"key":"3683_CR26","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1007\/s10238-025-01562-w","volume":"25","author":"AH Maleki","year":"2025","unstructured":"Maleki AH, Rajabivahid M, Khosh E, Khanali Z, Tahmasebi S, Ghorbi MD. Harnessing IL-27: challenges and potential in cancer immunotherapy. Clin Exp Med. 2025;25:34.","journal-title":"Clin Exp Med"},{"key":"3683_CR27","doi-asserted-by":"publisher","first-page":"314","DOI":"10.1038\/s41586-021-04127-5","volume":"600","author":"Q Wang","year":"2021","unstructured":"Wang Q, Li D, Cao G, Shi Q, Zhu J, Zhang M, et al. IL-27 signalling promotes adipocyte thermogenesis and energy expenditure. Nature. 2021;600:314\u20138.","journal-title":"Nature"},{"key":"3683_CR28","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1002\/glia.22948","volume":"64","author":"V S\u00e9n\u00e9cal","year":"2016","unstructured":"S\u00e9n\u00e9cal V, Deblois G, Beauseigle D, Schneider R, Brandenburg J, Newcombe J, et al. Production of IL-27 in multiple sclerosis lesions by astrocytes and myeloid cells: modulation of local immune responses. Glia. 2016;64:553\u201369.","journal-title":"Glia"},{"key":"3683_CR29","doi-asserted-by":"publisher","first-page":"2149","DOI":"10.4103\/1673-5374.336134","volume":"17","author":"AN Nortey","year":"2022","unstructured":"Nortey AN, Garces KN, Hackam AS. Exploring the role of interleukin-27 as a regulator of neuronal survival in central nervous system diseases. Neural Regen Res. 2022;17:2149.","journal-title":"Neural Regen Res"},{"key":"3683_CR30","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1186\/s12974-022-02576-x","volume":"19","author":"A Nortey","year":"2022","unstructured":"Nortey A, Garces K, Carmy-Bennun T, Hackam AS. The cytokine IL-27 reduces inflammation and protects photoreceptors in a mouse model of retinal degeneration. J Neuroinflammation. 2022;19:216.","journal-title":"J Neuroinflammation"},{"key":"3683_CR31","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1038\/s41586-024-08510-w","volume":"639","author":"B Br\u00e9art","year":"2025","unstructured":"Br\u00e9art B, Williams K, Krimm S, Wong T, Kayser BD, Wang L, et al. IL-27 elicits a cytotoxic CD8\u2009+\u2009T cell program to enforce tumour control. Nature. 2025;639:746\u201353.","journal-title":"Nature"},{"key":"3683_CR32","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1038\/s41586-024-07213-6","volume":"628","author":"E Martin","year":"2024","unstructured":"Martin E, Winter S, Garcin C, Tanita K, Hoshino A, Lenoir C, et al. Role of IL-27 in Epstein\u2013Barr virus infection revealed by IL-27RA deficiency. Nature. 2024;628:620\u20139.","journal-title":"Nature"},{"key":"3683_CR33","doi-asserted-by":"publisher","first-page":"2108","DOI":"10.1038\/s41590-023-01667-y","volume":"24","author":"C-H Lin","year":"2023","unstructured":"Lin C-H, Wu C-J, Cho S, Patkar R, Huth WJ, Lin L-L, et al. Selective IL-27 production by intestinal regulatory T cells permits gut-specific regulation of TH17 cell immunity. Nat Immunol. 2023;24:2108\u201320.","journal-title":"Nat Immunol"},{"key":"3683_CR34","doi-asserted-by":"crossref","unstructured":"Imamichi T, Bai X-F, Robinson C, Gee K, Editorial. IL-27 in health and disease. Front Immunol. 2023;14:1191228 .","DOI":"10.3389\/fimmu.2023.1191228"},{"key":"3683_CR35","doi-asserted-by":"publisher","first-page":"5235","DOI":"10.1007\/s10787-025-01901-z","volume":"33","author":"P Goleij","year":"2025","unstructured":"Goleij P, Amini A, Sanaye PM, Heidari MM, Tabari MAK, Aschner M, et al. The IL-12 family cytokines in neurodegenerative diseases: dual roles in neurotoxicity and neuroprotection. Inflammopharmacology. 2025;33:5235\u201356.","journal-title":"Inflammopharmacology"},{"key":"3683_CR36","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.clineuro.2018.01.022","volume":"166","author":"E Kouchaki","year":"2018","unstructured":"Kouchaki E, Kakhaki RD, Tamtaji OR, Dadgostar E, Behnam M, Nikoueinejad H, et al. Increased serum levels of TNF-\u03b1 and decreased serum levels of IL-27 in patients with Parkinson disease and their correlation with disease severity. Clin Neurol Neurosurg. 2018;166:76\u20139.","journal-title":"Clin Neurol Neurosurg"},{"key":"3683_CR37","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1111\/bph.16048","volume":"180","author":"S-Y Yao","year":"2023","unstructured":"Yao S-Y, Wang J-F, Xu Z, Meng Y, Xue Y, Yang F, et al. A peptide rich in glycine\u2013serine\u2013alanine repeats ameliorates Alzheimer-type neurodegeneration. Br J Pharmacol. 2023;180:1878\u201396.","journal-title":"Br J Pharmacol"},{"key":"3683_CR38","doi-asserted-by":"publisher","first-page":"11706","DOI":"10.1523\/JNEUROSCI.0730-12.2012","volume":"32","author":"Z Chen","year":"2012","unstructured":"Chen Z, Jalabi W, Shpargel KB, Farabaugh KT, Dutta R, Yin X, et al. Lipopolysaccharide-Induced microglial activation and neuroprotection against experimental brain injury is independent of hematogenous TLR4. J Neurosci. 2012;32:11706\u201315.","journal-title":"J Neurosci"},{"key":"3683_CR39","doi-asserted-by":"publisher","first-page":"2163","DOI":"10.1523\/JNEUROSCI.06-08-02163.1986","volume":"6","author":"D Giulian","year":"1986","unstructured":"Giulian D, Baker TJ. Characterization of ameboid microglia isolated from developing mammalian brain. J Neurosci. 1986;6:2163\u201378.","journal-title":"J Neurosci"},{"key":"3683_CR40","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/nprot.2006.116","volume":"1","author":"CV Vorhees","year":"2006","unstructured":"Vorhees CV, Williams MT. Morris water maze: procedures for assessing Spatial and related forms of learning and memory. Nat Protoc. 2006;1:848\u201358.","journal-title":"Nat Protoc"},{"key":"3683_CR41","first-page":"195","volume":"1","author":"J Knowles","year":"2006","unstructured":"Knowles J. Donepezil in alzheimer\u2019s disease: an evidence-based review of its impact on clinical and economic outcomes. Core Evid. 2006;1:195\u2013219.","journal-title":"Core Evid"},{"key":"3683_CR42","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1186\/s13195-024-01666-7","volume":"17","author":"JL Cummings","year":"2025","unstructured":"Cummings JL, Atri A, Feldman HH, Hansson O, Sano M, Knop FK, et al. Evoke and evoke+: design of two large-scale, double-blind, placebo-controlled, phase 3 studies evaluating efficacy, safety, and tolerability of semaglutide in early-stage symptomatic alzheimer\u2019s disease. Alzheimers Res Ther. 2025;17:14.","journal-title":"Alzheimers Res Ther"},{"key":"3683_CR43","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1038\/s43587-025-00869-3","volume":"5","author":"Y Zhang","year":"2025","unstructured":"Zhang Y, Chen H, Feng Y, Liu M, Lu Z, Hu B, et al. Activation of AMPK by GLP-1R agonists mitigates Alzheimer-related phenotypes in Transgenic mice. Nat Aging. 2025;5:1097\u2013113.","journal-title":"Nat Aging"},{"key":"3683_CR44","doi-asserted-by":"publisher","first-page":"101180","DOI":"10.1016\/j.molmet.2021.101180","volume":"47","author":"J Zheng","year":"2021","unstructured":"Zheng J, Xie Y, Ren L, Qi L, Wu L, Pan X, et al. GLP-1 improves the supportive ability of astrocytes to neurons by promoting aerobic Glycolysis in alzheimer\u2019s disease. Mol Metab. 2021;47:101180.","journal-title":"Mol Metab"},{"key":"3683_CR45","doi-asserted-by":"publisher","first-page":"101444","DOI":"10.1016\/j.arr.2021.101444","volume":"71","author":"ZP Van Acker","year":"2021","unstructured":"Van Acker ZP, Perdok A, Bretou M, Annaert W. The microglial lysosomal system in alzheimer\u2019s disease: guardian against proteinopathy. Ageing Res Rev. 2021;71:101444.","journal-title":"Ageing Res Rev"},{"key":"3683_CR46","doi-asserted-by":"crossref","unstructured":"Matejuk A, Ransohoff RM. Crosstalk between astrocytes and microglia: an overview. Front Immunol. 2020;11:1416 .","DOI":"10.3389\/fimmu.2020.01416"},{"key":"3683_CR47","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1016\/S1074-7613(02)00324-2","volume":"16","author":"S Pflanz","year":"2002","unstructured":"Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 Protein, induces proliferation of Naive CD4 T Cells+. Immunity. 2002;16:779\u201390.","journal-title":"Immunity"},{"key":"3683_CR48","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1152\/physiolgenomics.00208.2006","volume":"28","author":"WS Liang","year":"2007","unstructured":"Liang WS, Dunckley T, Beach TG, Grover A, Mastroeni D, Walker DG, et al. Gene expression profiles in anatomically and functionally distinct regions of the normal aged human brain. Physiol Genomics. 2007;28:311\u201322.","journal-title":"Physiol Genomics"},{"key":"3683_CR49","doi-asserted-by":"publisher","first-page":"1838","DOI":"10.1007\/s12031-021-01802-0","volume":"71","author":"C Luo","year":"2021","unstructured":"Luo C, Li B, Chen L, Zhao L, Wei Y. IL-27 protects the brain from Ischemia-Reperfusion injury via the gp130\/STAT3 signaling pathway. J Mol Neurosci. 2021;71:1838\u201348.","journal-title":"J Mol Neurosci"},{"key":"3683_CR50","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1038\/s41467-017-00770-7","volume":"8","author":"X Zhao","year":"2017","unstructured":"Zhao X, Ting S-M, Liu C-H, Sun G, Kruzel M, Roy-O\u2019Reilly M, et al. Neutrophil polarization by IL-27 as a therapeutic target for intracerebral hemorrhage. Nat Commun. 2017;8:602.","journal-title":"Nat Commun"},{"key":"3683_CR51","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1016\/j.tins.2020.08.008","volume":"43","author":"L-P Bernier","year":"2020","unstructured":"Bernier L-P, York EM, MacVicar BA. Immunometabolism in the brain: how metabolism shapes microglial function. Trends Neurosci. 2020;43:854\u201369.","journal-title":"Trends Neurosci"},{"key":"3683_CR52","doi-asserted-by":"publisher","first-page":"575","DOI":"10.1038\/s41586-019-1678-1","volume":"574","author":"D Zhang","year":"2019","unstructured":"Zhang D, Tang Z, Huang H, Zhou G, Cui C, Weng Y, et al. Metabolic regulation of gene expression by histone lactylation. Nature. 2019;574:575\u201380.","journal-title":"Nature"},{"key":"3683_CR53","first-page":"374","volume":"620","author":"MF Gulen","year":"2023","unstructured":"Gulen MF, Samson N, Keller A, Schwabenland M, Liu C, Gl\u00fcck S, et al. cGAS\u2013STING Drives ageing-related Inflamm Neurodegeneration. 2023;620:374\u201380.","journal-title":"cGAS\u2013STING Drives ageing-related Inflamm Neurodegeneration"},{"key":"3683_CR54","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1038\/s41586-024-07992-y","volume":"634","author":"H Li","year":"2024","unstructured":"Li H, Liu C, Li R, Zhou L, Ran Y, Yang Q, et al. AARS1 and AARS2 sense l-lactate to regulate cGAS as global lysine lactyltransferases. Nature. 2024;634:1229\u201337.","journal-title":"Nature"},{"key":"3683_CR55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1146\/annurev-immunol-032414-112134","volume":"33","author":"H Yoshida","year":"2015","unstructured":"Yoshida H, Hunter CA. The immunobiology of Interleukin-27. Annu Rev Immunol. 2015;33:417\u201343.","journal-title":"Annu Rev Immunol"},{"key":"3683_CR56","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/s41573-020-0072-x","volume":"19","author":"SC Cunnane","year":"2020","unstructured":"Cunnane SC, Trushina E, Morland C, Prigione A, Casadesus G, Andrews ZB, et al. Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing. Nat Rev Drug Discov. 2020;19:609\u201333.","journal-title":"Nat Rev Drug Discov"},{"key":"3683_CR57","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1016\/j.autrev.2015.08.001","volume":"14","author":"RR Meka","year":"2015","unstructured":"Meka RR, Venkatesha SH, Dudics S, Acharya B, Moudgil KD. IL-27-induced modulation of autoimmunity and its therapeutic potential. Autoimmun Rev. 2015;14:1131\u201341.","journal-title":"Autoimmun Rev"},{"key":"3683_CR58","doi-asserted-by":"crossref","unstructured":"An J, Fu D, Chen X, Guan C, Li L, Bai J et al. Revisiting the role of IL-27 in obesity-related metabolic diseases: safeguard or perturbation? Front Immunol. 2025;15:1498288 .","DOI":"10.3389\/fimmu.2024.1498288"},{"key":"3683_CR59","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/nm.4443","volume":"24","author":"Z He","year":"2018","unstructured":"He Z, Guo JL, McBride JD, Narasimhan S, Kim H, Changolkar L, et al. Amyloid-\u03b2 plaques enhance alzheimer\u2019s brain Tau-seeded pathologies by facilitating neuritic plaque Tau aggregation. Nat Med. 2018;24:29\u201338.","journal-title":"Nat Med"}],"container-title":["Journal of Neuroinflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12974-025-03683-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12974-025-03683-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T16:02:55Z","timestamp":1770652975000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12974-025-03683-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,13]]},"references-count":59,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["3683"],"URL":"https:\/\/doi.org\/10.1186\/s12974-025-03683-1","relation":{},"ISSN":["1742-2094"],"issn-type":[{"value":"1742-2094","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,13]]},"assertion":[{"value":"16 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"58"}}